Investigational new drug enabling angiotensin oral-delivery studies to attenuate pulmonary hypertension.
Daniell H, Mangu V, Yakubov B, Park J, Habibi P, Shi Y, Gonnella PA, Fisher A, Cook T, Zeng L, Kawut SM, Lahm T.
Daniell H, et al. Among authors: habibi p.
Biomaterials. 2020 Mar;233:119750. doi: 10.1016/j.biomaterials.2019.119750. Epub 2019 Dec 30.
Biomaterials. 2020.
PMID: 31931441
Free PMC article.